Epilepsy Currents, volume 21, issue 3, pages 150-153
FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force
Jacqueline A. French
1, 2
,
Emilio Perucca
3
,
JOSEMIR W. SANDER
4, 5, 6
,
Lennart Bergfeldt
7, 8
,
Michel Baulac
9
,
David S. Auerbach
10
,
Mark R. Keezer
6, 11
,
Roland D. Thijs
5, 6, 12
,
Orrin Devinsky
1, 2
,
David G. Vossler
13
,
Timothy E. Welty
14
4
Chalfont Centre for Epilepsy, Chalfont St. Peter, United Kingdom
|
5
UCL Queen Square Institute of Neurology, London, United Kingdom
|
6
Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands
|
10
Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, USA
|
14
College of Pharmacy and Health Sciences, Drake University, Des Moines, IA, USA
|
Publication type: Journal Article
Publication date: 2021-02-28
Journal:
Epilepsy Currents
scimago Q3
SJR: 0.513
CiteScore: 2.4
Impact factor: 5.8
ISSN: 15357597, 15357511
Neurology (clinical)
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.